Abstract
Tissue engineered blood vessel is a new candidate for tissue substitution in clinics. Currently, endothelial cells are deemed as first-line seed cells, but restricted in further application for the lack of donor sources. Meanwhile, embryonic stem (ES) cells are expected to be a new source of seed cells because of their unlimited self-renewing capacity and multilineage differentiation potential.In this study, we did some research on human ES cells in an attempt to expend new sources of seeding cells for tissue engineering of blood vessel.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
